Hikma Pharmaceuticals PLC:戦略・SWOT・企業財務分析

◆英語タイトル:Hikma Pharmaceuticals PLC - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA8015324
◆発行会社(調査会社):MarketLine
◆発行日:2017年9月30日
◆ページ数:53
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Hikma Pharmaceuticals PLC – Strategy, SWOT and Corporate Finance Report
Summary

Hikma Pharmaceuticals PLC – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Hikma Pharmaceuticals (Hikma or ‘the company’) is engaged in the development, manufacture and marketing of generic and in-licensed pharmaceutical products. The company primarily operates in the Middle East and North Africa (MENA), the US and Europe. It is headquartered in London, the UK and employs around 7,248 people.

Scope

- Detailed information on Hikma Pharmaceuticals PLC required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Hikma Pharmaceuticals PLC in the form of a SWOT analysis
- An in-depth view of the business model of Hikma Pharmaceuticals PLC including a breakdown and examination of key business segments
- Intelligence on Hikma Pharmaceuticals PLC’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Hikma Pharmaceuticals PLC, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Hikma Pharmaceuticals PLC and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Hikma Pharmaceuticals PLC as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Hikma Pharmaceuticals PLC’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Hikma Pharmaceuticals PLC: Company Overview
Hikma Pharmaceuticals PLC: Overview and Key Facts
Hikma Pharmaceuticals PLC: Overview
Hikma Pharmaceuticals PLC: Key Facts
Hikma Pharmaceuticals PLC: Key Employees
Hikma Pharmaceuticals PLC: Key Employee Biographies
Hikma Pharmaceuticals PLC: Major Products and Services
Hikma Pharmaceuticals PLC: Company History
Hikma Pharmaceuticals PLC: Management Statement
Hikma Pharmaceuticals PLC: Locations and Subsidiaries
Hikma Pharmaceuticals PLC: Key Competitors
Hikma Pharmaceuticals PLC: Company Analysis
Hikma Pharmaceuticals PLC: Business Description
Hikma Pharmaceuticals PLC: SWOT Analysis
Hikma Pharmaceuticals PLC: SWOT Overview
Hikma Pharmaceuticals PLC: Strengths
Hikma Pharmaceuticals PLC: Weaknesses
Hikma Pharmaceuticals PLC: Opportunities
Hikma Pharmaceuticals PLC: Threats
Hikma Pharmaceuticals PLC: Corporate Financial Deals Activity
Hikma Pharmaceuticals PLC: Financial Deals Overview
Hikma Pharmaceuticals PLC: Targets and Partners
Hikma Pharmaceuticals PLC: Top Deals 2013 – 2017YTD*
Hikma Pharmaceuticals PLC: Advisors
Hikma Pharmaceuticals PLC: Top Legal Advisors
Hikma Pharmaceuticals PLC: Top Financial Advisors
Hikma Pharmaceuticals PLC: Mergers and Acquisitions
Hikma Pharmaceuticals PLC: Partnership
Hikma Pharmaceuticals PLC: Divestments
Hikma Pharmaceuticals PLC: Recent Developments
Hikma Pharmaceuticals PLC: News and Events Summary
Hikma Pharmaceuticals PLC: Business Expansion
Hikma Pharmaceuticals PLC: Corporate Governance
Hikma Pharmaceuticals PLC: Financial Deals
Hikma Pharmaceuticals PLC: Financial Performance
Hikma Pharmaceuticals PLC: Regulatory and Legal Events
Hikma Pharmaceuticals PLC: Research & Development
Hikma Pharmaceuticals PLC: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
About MarketLine

List of Tables
Table 1: Hikma Pharmaceuticals PLC: Key Facts
Table 2: Hikma Pharmaceuticals PLC: Key Employees
Table 3: Hikma Pharmaceuticals PLC: Locations and Subsidiaries
Table 4: Hikma Pharmaceuticals PLC: Key Competitors
Table 5: Hikma Pharmaceuticals PLC: Deal Activity by Deal Type - Volume (2013 - YTD*2017)
Table 6: Hikma Pharmaceuticals PLC: M&A Average Deal Size - Value (US$m)
Table 7: Hikma Pharmaceuticals PLC: Targets and Partners
Table 8: Hikma Pharmaceuticals PLC: Top Deals 2013 - 2017YTD*
Table 9: Hikma Pharmaceuticals PLC: Legal Advisor Ranking by Value (US$m)
Table 10: Hikma Pharmaceuticals PLC: Financial Advisor Ranking by Value (US$m)
Table 11: Hikma Pharmaceuticals PLC: M&A Volume and Value Trend (2013 - YTD*2017)
Table 12: Hikma Pharmaceuticals PLC: M&A Activity by Geography (2013 - YTD*2017)
Table 13: Hikma Pharmaceuticals PLC: Partnership Volume and Value Trend (2013 - YTD*2017)
Table 14: Hikma Pharmaceuticals PLC: Partnership Trend by Deal Type (2013 - YTD*2017)
Table 15: Hikma Pharmaceuticals PLC: Divestments Volume and Value Trend (2013 - YTD*2017)
Table 16: Hikma Pharmaceuticals PLC: News and Events Summary
Table 17: Hikma Pharmaceuticals PLC: Business Expansion
Table 18: Hikma Pharmaceuticals PLC: Corporate Governance
Table 19: Hikma Pharmaceuticals PLC: Financial Deals
Table 20: Hikma Pharmaceuticals PLC: Financial Performance
Table 21: Hikma Pharmaceuticals PLC: Regulatory and Legal Events
Table 22: Hikma Pharmaceuticals PLC: Research & Development
Table 23: Hikma Pharmaceuticals PLC: Strategy and Operations

★海外企業調査レポート[Hikma Pharmaceuticals PLC:戦略・SWOT・企業財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ABPA Holdings Limited:企業の戦略的SWOT分析
    ABPA Holdings Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Polenergia SA (PEP):電力:M&Aディール及び事業提携情報
    Summary Polenergia SA (Polenergia) formerly Polish Energy Partners SA develops, implements and operates projects related to production of electricity and fuels. It offers services such as project implementation and supervision of construction, management of power facilities, production and sales of …
  • Companhia Energetica de Sao Paulo (CESP6):企業の財務・戦略的SWOT分析
    Companhia Energetica de Sao Paulo (CESP6) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Tongaat Hulett Ltd:企業の戦略的SWOT分析
    Tongaat Hulett Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Bio Blast Pharma Ltd (ORPN):製薬・医療:M&Aディール及び事業提携情報
    Summary Bio Blast Pharma Ltd (Bioblast Pharma) is a clinical stage biotechnology company that discovers, delivers, and develops clinical therapies for patients with rare and ultra-rare genetic diseases. The company discovers and develops pipeline products using platforms such as cabaletta, a mutant …
  • The Interpublic Group of Companies, Inc.:戦略・SWOT・企業財務分析
    The Interpublic Group of Companies, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Interpublic Group of Companies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Microsoft Corporation:企業のM&A・事業提携・投資動向
    Microsoft Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Microsoft Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Virgin Active Limited:企業の戦略・SWOT・財務分析
    Virgin Active Limited - Strategy, SWOT and Corporate Finance Report Summary Virgin Active Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Mitsubishi Electric Corporation:企業の戦略・SWOT・財務情報
    Mitsubishi Electric Corporation - Strategy, SWOT and Corporate Finance Report Summary Mitsubishi Electric Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Verizon Communications Inc (VZ):企業の財務・戦略的SWOT分析
    Verizon Communications Inc (VZ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Lotte Chemical Corp (011170):企業の財務・戦略的SWOT分析
    Lotte Chemical Corp (011170) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Quantum Utility Generation LLC:電力:M&Aディール及び事業提携情報
    Summary Quantum Utility Generation LLC (QUG) is an electric utility that acquires, develops, operates and optimizes power generation assets in the Americas. The utility generates electricity from various sources such as wind, coal and natural gas-based power generation plants. It also produces elect …
  • High Energy Batteries (India) Ltd:企業の戦略・SWOT・財務分析
    High Energy Batteries (India) Ltd - Strategy, SWOT and Corporate Finance Report Summary High Energy Batteries (India) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Telstra Corporation Ltd (TLS):企業の財務・戦略的SWOT分析
    Telstra Corporation Ltd (TLS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Infineon Technologies AG (IFX):企業の財務・戦略的SWOT分析
    Infineon Technologies AG (IFX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Air Total International SA:企業の戦略的SWOT分析
    Air Total International SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Five Prime Therapeutics Inc (FPRX):医療機器:M&Aディール及び事業提携情報
    Summary Five Prime Therapeutics Inc (Five Prime) is a clinical state biopharmaceutical company focusing on the research and development of novel treatments for cancer and inflammatory disorders. The company’s developmental pipeline is based on the discovery platform and library of therapeutic protei …
  • Pental Limited (PTL):企業の財務・戦略的SWOT分析
    Pental Limited (PTL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Oncolytics Biotech Inc (ONC)-製薬・医療分野:企業M&A・提携分析
    Summary Oncolytics Biotech Inc (Oncolytics) is a development stage biopharmaceutical company which focuses on the discovery and development of oncolytic viruses for the treatment of cancer. The company’s lead product, Reolysin, a formulation of the human reovirus, is at Phase II clinical trials indi …
  • American States Water Company (AWR):企業の財務・戦略的SWOT分析
    Summary American States Water Company (AWR) operates as a utility service provider that offers water, wastewater and electric services. The utility provides operation, construction management and maintenance services for water and wastewater systems located on military bases across the US. It offers …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆